{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:11:24Z","timestamp":1784196684247,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ophtha.2007.01.025","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T09:03:09Z","timestamp":1177578189000},"page":"2244-2251.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on Circadian Intraocular Pressure"],"prefix":"10.1016","volume":"114","author":[{"given":"Luca","family":"Rossetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas H.","family":"Karabatsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotis","family":"Topouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Vetrugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Centofanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vorwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.01.025_bib1","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ophtha.2007.01.025_bib2","first-page":"1937","article-title":"Open-angle glaucoma","volume":"67","author":"Distelhorst","year":"2003","journal-title":"Am Fam Physician"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.01.025_bib3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0039-6257(02)00291-6","article-title":"Changing paradigms in the medical treatment of glaucoma","volume":"47","author":"Soltau","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib4","first-page":"692","article-title":"Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma?","volume":"86","author":"Anton","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib5","first-page":"693","article-title":"Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma?","volume":"86","author":"Skuta","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0039-6257(01)00286-7","article-title":"Primary drug treatment for glaucoma: beta-blockers versus other medications","volume":"47","author":"Stamper","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.01.025_bib7","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S0039-6257(02)00290-4","article-title":"Latanoprost versus combined timolol and dorzolamide","volume":"47","author":"Bron","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00417-002-0469-8","article-title":"Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up","volume":"240","author":"Costagliola","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bjo.85.8.983","article-title":"Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension","volume":"85","author":"Zhang","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.12968\/hosp.2003.64.3.1798","article-title":"New drugs in glaucoma therapy","volume":"64","author":"Cunliffe","year":"2003","journal-title":"Hosp Med"},{"key":"10.1016\/j.ophtha.2007.01.025_bib11","first-page":"109","article-title":"Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects","volume":"100","author":"Halpern","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.01.025_bib12","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0039-6257(02)00327-2","article-title":"Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs","volume":"47","author":"Eisenberg","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14656566.3.7.965","article-title":"Travoprost\u2014a new prostaglandin analogue for the treatment of glaucoma","volume":"3","author":"Whitson","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ophtha.2007.01.025_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00061198-200110000-00010","article-title":"Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension","volume":"10","author":"Goldberg","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2007.01.025_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjo.87.1.57","article-title":"A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension","volume":"87","author":"Whitcup","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archopht.120.10.1286","article-title":"One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension","volume":"120","author":"Higginbotham","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized clinical trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib20","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib21","first-page":"21","article-title":"Terminology and Guidelines for Glaucoma","year":"2003"},{"key":"10.1016\/j.ophtha.2007.01.025_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2710.2005.00641.x","article-title":"Cost considerations of the new fixed combinations for glaucoma medical therapy","volume":"30","author":"Ventura","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ophtha.2007.01.025_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archopht.120.7.915","article-title":"Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial","volume":"120","author":"Higginbotham","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ophtha.2005.11.011","article-title":"Efficacy of latanoprost or fixed-combination latanoprost\u2013timolol in patients switched from a combination of timolol and a nonprostaglandin medication","volume":"113","author":"Magacho","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/jop.2004.20.375","article-title":"Intraocular pressure and safety in glaucoma patients switching to latanoprost\/timolol maleate fixed combination from mono- and adjunctive therapies","volume":"20","author":"Konstas","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2007.01.025_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ophtha.2005.06.027","article-title":"A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components","volume":"113","author":"Diestelhorst","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effect of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib29","first-page":"130","article-title":"Clinical Trials: A Practical Approach","author":"Pocock","year":"1983"},{"key":"10.1016\/j.ophtha.2007.01.025_bib30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs","volume":"112","author":"van der Valk","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ophtha.2005.10.045","article-title":"Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"113","author":"Orzalesi","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ophtha.2004.08.022","article-title":"Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients","volume":"112","author":"Konstas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.01.025_bib33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","article-title":"A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study","volume":"135","author":"Parrish","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.01.025_bib34","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.survophthal.2003.12.017","article-title":"24-hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial","volume":"49","author":"Walters","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02850259","article-title":"Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension","volume":"20","author":"Noecker","year":"2003","journal-title":"Adv Ther"},{"key":"10.1016\/j.ophtha.2007.01.025_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(02)01827-5","article-title":"A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma","volume":"135","author":"Noecker","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/112067210001000201","article-title":"A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol","volume":"10","author":"Hedman","year":"2000","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02850348","article-title":"Prospective comparative switch study from timolol 0.5% and latanoprost 0.005% to bimatoprost 0.03%","volume":"23","author":"Brittain","year":"2006","journal-title":"Adv Ther"},{"key":"10.1016\/j.ophtha.2007.01.025_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjo.2003.018234","article-title":"A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension","volume":"88","author":"Diestelhorst","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.025_bib40","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archopht.123.7.898","article-title":"Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy","volume":"123","author":"Konstas","year":"2005","journal-title":"Arch Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:53:05Z","timestamp":1758981185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0161642007001194"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.025","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on Circadian Intraocular Pressure","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}